EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients. (Q54417851)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

ovarian carcinoma

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Zhi-Yue Rao

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Mu-Yan Cai

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Guo-Fen Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Li-Ru He

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Shi-Juan Mai

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Wen-Feng Hua

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yi-Ji Liao

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Hai-Xia Deng

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yang-Chao Chen

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yi-Xin Zeng

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Hsiang-Fu Kung

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Dan Xie

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

0 references

publication date

28 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1576-1583

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Epidemiological and molecular aspects of ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Roles of the EZH2 histone methyltransferase in cancer epigenetics

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

The polycomb group protein EZH2 is involved in progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Oncogenic transformation by SEI-1 is associated with chromosomal instability

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Activated p53 suppresses the histone methyltransferase EZH2 gene

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Overexpression of latent transforming growth factor-beta 1 (TGF-beta 1) binding protein 1 (LTBP-1) in association with TGF-beta 1 in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Epithelial-mesenchymal transformation of a newly established cell line from ovarian adenosarcoma by transforming growth factor-beta1.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Heterogeneous expression and association of ?-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54417851&oldid=1506790308"